ALK and non-small cell lung carcinoma: Multiple studies have been carried out to determine the frequency of EML4–ALK translocation occurrences in patients with NSCLC, ranging from 1.6% to 11.7% in individual studies [7–18] with an averaged frequency at about 5%, estimated from published results [6].